Anti-glomerular basement membrane (anti-GBM) disease is quite rare, with an estimated incidence of 1 to 2 cases per million. It causes 1% to 2% of all cases of glomerulonephritis. In one series, anti-GBM antibodies were found in 15% of patients presenting with a pulmonary renal syndrome. Between 30% to 50% of patients with anti-GBM disease also have positive anti-neutrophil cytoplasmic antibodies. There is a male predominance with cases divided approximately 60% male, 40% female. There are 2 age peaks: at 20 to 30 years, and at 60 to 70 years. Approximately 83% of cases occur in white people. In Chinese patients, the incidence is 0.6 cases per million population per year.
BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.
To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.
You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.
Use of this content is subject to our disclaimer